Market Tracker

06/28 5:16pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

2.54
Delayed Data
As of Jun 28
 -2.47 / -49.30%
Today’s Change
2.44
Today|||52-Week Range
11.59
-70.87%
Year-to-Date

Today’s Trading

Previous close5.01
Today’s open2.63
Day’s range2.44 - 2.87
Volume6,915,683
Average volume (3 months)865,953
Market cap$264.4M
Dividend yield--
Data as of 4:00pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)+16.28%
Earnings growth (this year)-42.48%
Earnings growth (next 5 years)--
Revenue growth (last year)+170.69%
P/E ratioNM
Price/Sales21.60
Price/Book2.13

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc+0.49+6.30%
CRHMCRH Medical Corp+0.01+0.31%
TBRATobira Therapeutics ...-1.07-7.46%
CRVSCorvus Pharmaceutica...+0.61+4.57%
Data as of 4:00pm ET, 06/28/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$20.8M
Annual profit (last year)-$55.7M
Net profit margin-268.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts